About Grove AI
Grove AI is a clinical trial technology company that deploys agentic AI solutions to accelerate clinical research operations at scale. The company's flagship product, Grace, is an AI-powered Digital Staff agent that automates participant recruitment, prescreening, scheduling, and engagement across the clinical trial lifecycle. Grace operates 24/7 in multiple languages, responding to participant inquiries in under 30 seconds and seamlessly integrating with existing clinical trial management systems. The Grove AI PRM (Participant Relationship Management) platform unifies all participant interactions in a single intelligent system, enabling real-time optimization of recruitment workflows. Grove AI serves leading site networks, contract research organizations (CROs), and pharmaceutical sponsors conducting Phase I through Phase III clinical trials. The company's solutions have demonstrated significant impact, including a 2.7x increase in enrollment rates, 28% improvement in screening pass rates, and 580% increase in scheduled on-site visits. Grove AI has processed over 9.9 million participant queries, scheduled nearly 30,000 appointments, and saved over 56,500 hours in manual workflows. The company is backed by world-class investors and advised by former executives from Novartis, UCB, ICON, Google, and other leading healthcare and technology organizations. In January 2026, Grove AI was acquired by Hippocratic AI, marking a significant milestone in the company's growth trajectory.
Mission & Story
Mission
Advancing Next-Generation Life Sciences with Agentic AI
Founding Story
Grove AI was founded by a team of leading AI engineers and researchers with the mission to enable life sciences organizations to accelerate operations at scale using data and agentic AI. The founding team includes advisors and team members who have worked at leading organizations including Novartis, UCB, ICON, Google, and Datadog.
Clinical Focus
Medical conditions and clinical areas addressed by Grove AI.
Who It Serves
Milestones & Awards
Recent Milestones
Acquired by Hippocratic AI (January 2026). Achieved ISO 42001 Certification (October 2025). Launched Agent Operator platform (October 2025). Named finalist for 2025 Pantheon Awards and Citeline Innovative Clinical Trial Solutions Award. Announced Clinical Research Site Advisory Council (August 2025). Unveiled PRM platform (May 2025). Grace received Generic IRB Approval (April 2025).
Awards & Recognition
Finalist for 2025 Pantheon Awards. Finalist for Citeline Innovative Clinical Trial Solutions Award. SCOPE 2025 Participant Engagement Award Finalist. Featured on Citeline's In Vivo Podcast.
Key Partnerships
Social & Media
Follow on
Company Details
- Headquarters
- San Francisco, CA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.